APA (7th ed.) Citation

BM, W., R, V., AS, B., J, A., N, T., C, M., . . . D, K. (2025). Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. PloS one, 20(2), e0316952. https://doi.org/10.1371/journal.pone.0316952

Chicago Style (17th ed.) Citation

BM, Warner, et al. "Treatment with the CCR5 Antagonist OB-002 Reduces Lung Pathology, but Does Not Prevent Disease in a Syrian Hamster Model of SARS-CoV-2 Infection." PloS One 20, no. 2 (2025): e0316952. https://doi.org/10.1371/journal.pone.0316952.

MLA (9th ed.) Citation

BM, Warner, et al. "Treatment with the CCR5 Antagonist OB-002 Reduces Lung Pathology, but Does Not Prevent Disease in a Syrian Hamster Model of SARS-CoV-2 Infection." PloS One, vol. 20, no. 2, 2025, p. e0316952, https://doi.org/10.1371/journal.pone.0316952.